Skip to main content
Premium Trial:

Request an Annual Quote

IDBS Expands US Headquarters to Include Healthcare Center of Excellence


This week, IDBS expanded its office in Burlington, Mass., to include a Healthcare Center of Excellence to support its efforts on the translational medicine front.

The center is expected to support IDBS' personalized medicine activities through collaborations with the local and international health science ecosystem, the company said.

The company opened a US-based headquarters for its healthcare business last July and added 22 full-time employees to better serve its customers in the space.

At the time, IDBS' Founder and CEO Neil Kipling said that the Burlington office was "a natural US hub" for company pursuits in the translational medicine market, and that the concentration of clinical research efforts, life sciences research and development, and industrial-academic collaborations provided "an ideal environment to expand our R&D business and to create our US Center of Excellence for Healthcare."

The company has existing relationships with the Dana-Farber Cancer Institute, Selventa, Merck, Biogen, Shire, and Novartis, among other life sciences groups that are located in the region.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.